Bay Street News, 2023

VANCOUVER, British Columbia, Dec. 27, 2023 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or […]

BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX) a clinical-stage biopharmaceutical company developing a new class […]

DUBAI, United Arab Emirates, Dec. 27, 2023 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a […]

BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the […]

Opthea to receive remaining US$35m funding under the Development Funding Agreement (DFA) with Carlyle and its life science franchise Abingworth, […]

GUANGZHOU, China, Dec. 27, 2023 (GLOBE NEWSWIRE) — Puyi Inc. (NASDAQ: PUYI) (“Puyi”), a leading third-party wealth management services provider […]

HOLMDEL, N.J. and MADRID, Spain, Dec. 27, 2023 (GLOBE NEWSWIRE) — BIO-key®International, Inc. (NASDAQ: BKYI), an innovative provider of workforce […]

GUANGZHOU, China, Dec. 27, 2023 (GLOBE NEWSWIRE) — FANHUA Inc. (“FANHUA” or “the Company”) (Nasdaq: FANH), a leading independent financial […]

SHANGHAI, China, Dec. 27, 2023 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), […]

TORONTO, ONTARIO, Dec. 27, 2023 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company”) Admission to OMX Iceland 15 Index TORONTO, ONTARIO […]